期刊文献+

5-氟尿嘧啶腹腔气雾化疗的药代动力学及组织分布 被引量:1

Pharmacokinetics and tissue distribution of intraperitoneal aerosol 5-fluorouracil in rats
原文传递
导出
摘要 目的观察5-氟尿嘧啶(5-Fu)以CO:为载体行腹腔气雾化疗的药代动力学及组织分布。方法将30只SD大鼠随机分为1、3、6、12、18、24h时间点组;用自行研制的气雾化疗仪将5-Fu气雾化后行腹腔灌注(0.1ml/g),在相应时间点抽取门静脉及下腔静脉血,取出结肠、胃、肝、肾及肺脏组织,用高效液相色谱法(HPLC)测定其中5.Fu浓度。结果腹腔液、门静脉及下腔静脉血,结肠、胃、肝、肾及肺脏组织中的药物浓度峰值均出现在1h组,药物浓度均随时间延长呈递减趋势;腹腔液中的药物浓度在1h组中达到峰值(259.7730mg/L);在1h组中门静脉(PV)血中药物浓度浓度(7.4933mg/L)是下腔静脉(ICV,5.5930mg/L)的1.3倍;组织中肾脏浓度最高,1h组浓度为2.4030mg/L,肺、胃浓度次之,结肠、肝组织中浓度依次较低。结论5-Fu腹腔气雾化疗具有其药代动力学优势,有望有效杀灭游离癌细胞和微小癌灶。 Objective To study the pharmacokinetics and tissue distribution of intraperitoneal aerosol 5-fluorouracil (5-Fu) in rats. Methods Thirty SD rats were randomized into 1, 3, 6, 12, 18, 24 h time point groups; the 5-Fu (0. 1 ml/g) in aerosol was perfused into the abdominal cavities of rats with self-developed instrument. The blood of the portal vein and inferior vena cava, and samples of the colon, stomach, liver, kidney and lung were collected on the corresponding time points ; the concentrations of 5- Fu in the samples were determinated by using high performance liquid chromatography (HPLC). Results The peak drug concentrations of the peritoneal fluid, blood of the portal vein and inferior vena cava, tissues of the colon, stomach, liver, kidney and lung all appeared in the 1 h group, and drug concentration was decreased along with time ; the peak drug concentration of peritoneal fluid in 1 h group was 259. 7730 mg/L. The peak drug concentration of portal vein blood in the 1 h group was 7. 4933 mg/L, about 1.3 times higher than that of inferior vena cava blood (5. 5930 mg/L). Among the visceral organs, the peak drug concentration of renal tissue (2. 4030 mg/L) in 1 h group was highest, followed by that of the lung, stomach, colon, liver in turn. Conclusion Intraperitoneal aerosol chemotherapy with 5-Fu has pharmacokinetic advantages, which can kill free cancer cells and micro-cancers probably.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第1期45-47,共3页 Chinese Journal of Experimental Surgery
基金 广东省科技计划资助项目(2006812901006) 广州市科技攻关计划资助项目(200623-E0571)
关键词 腹腔气雾化疗 药代动力学 腹腔镜 5-氟尿嘧啶 高效液相色谱法 Intraperitoneal aerosol chemotherapy Pharmacokinetics Laparoscopy 5-Fu High-performance liquid chromatography
  • 相关文献

参考文献3

二级参考文献35

  • 1高枫,陈利生,唐宗江,张志勇,刘小健.术中腹腔内温热灌注化疗联合治疗中晚期大肠癌[J].中华实验外科杂志,1995,12(3):151-152. 被引量:19
  • 2卿三华,周锡庚,周正端,齐德林,姚明,梁立德.大剂量大容积5-氟脲嘧啶腹腔化疗治疗结直肠癌的实验和临床研究[J].中华肿瘤杂志,1996,18(2):92-92. 被引量:7
  • 3[8]Roseushein N,Blake D,McIntyre PA,Parmley T,Natarajan TK,Dvornicky J,Nickoloff E.The effect of volume on the distribution of substances instilled into the peritoneal cavity.Gynecol Onco11978; 6:106-110
  • 4[9]Pestieau SR,Schnake KJ,Stuart OA,Sugarbaker PH.Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.Cancer Chemother Pharmaco12001; 47:269-276
  • 5[10]Rowinsky EK,Donehower RC,Jones RJ,Tucker RW.Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.Cancer Res 1988; 48:4093-4100
  • 6[11]Kerr DJ,Young AM,Neoptolemos JP,Sherman M,Van-Geene P,Stanley A,Ferry D,Dobbie JW,Vincke B,Gilbert J,el Eini D,Dombros N,Fountzilas G.Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.Br J Cancer 1996; 74:2032-2035
  • 7[12]McArdle CS,Kerr DJ,O'Gorman P,Wotherspoon HA,Warren H,Watson D,Vinke BJ,Dobbie JW,el Eini DI.Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution-a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.Br J Cancer 1994; 70:762-766
  • 8[13]Dobbie JW.New principles,better practices,and clearer perceptions in intraperitoneal chemotherapy:clinical experience using icodextrin 20 as a carrier solution.Adv Perit Dial 1997; 13:162-167
  • 9[14]Mohamed F,Marchettini P,Stuart OA,Sugarbaker PH.Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.Cancer Chemother Pharmaco12003; 52:405-410
  • 10[15]Mohamed F,Stuart OA,Sugarbaker PH.Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different arrier solutions.J Surg Res 2003; 113:114-120

共引文献12

同被引文献6

  • 1Wang Z, Zhang X, Xu H, et al. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples[J]. J Surg Oncol, 2005, 90(2): 59-65.
  • 2Sugarbaker PH. Adjuvant intraperitoneal chemotherapy for advanced primary gastric cancer [J]. Scand J Surg, 2006, 95(4): 270-3.
  • 3Shen MY, Huang IP, Chen WS, et al. Influence of pneumoperitoneum on tumor growth and pattern of intra-abdominal tumor spreading: in vivo study of a murine model[J]. Hepatogastroenterology, 2008, 55 (84): 947-51.
  • 4Yah TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer [J]. Ann Surg Oncol, 2007, 14(10): 2702-13.
  • 5Zanon C, Bortolini M, Chiappino I, et al. Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer[J]. World J Surg, 2006, 30(11): 2025-32.
  • 6Bartek J, Lukas J. Mammalian G1-and S-phase checkpoints in response to DNA damage [J]. Curr Opin Cell Biol, 2001, 13(6): 738-47.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部